Patients in medical treatment for attention deficit/hyperactivity disorder (adhd): are they at risk in drug screening?

HIGHLIGHTS

• who: Christina Mohr Jensen from the Child and Adolescent Psychiatry, Aalborg University Hospital, Mlleparkvej, Aalborg DKu20119000, Denmark have published the research work: Patients in medical treatment for attention deficit/hyperactivity disorder (ADHD): Are they at risk in drug screening?, in the Journal: (JOURNAL)
• what: While drug testing has its benefits and can be justified in certain clinical situations, we have outlined some critical, ethical aspects that needs more attention in both clinical practice and research.
• how: This Article discusses the risk of u2018false positive` results or post-analytical misinterpretations of results when immunoassays . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.